nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Carmustine—melanoma	0.167	0.229	CbGbCtD
Rimonabant—CYP1A2—Vemurafenib—melanoma	0.132	0.181	CbGbCtD
Rimonabant—CYP3A4—Temozolomide—melanoma	0.126	0.173	CbGbCtD
Rimonabant—CYP2D6—Vemurafenib—melanoma	0.109	0.149	CbGbCtD
Rimonabant—CYP1A2—Dacarbazine—melanoma	0.101	0.139	CbGbCtD
Rimonabant—CYP3A4—Vemurafenib—melanoma	0.0693	0.095	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—melanoma	0.0238	0.0326	CbGbCtD
Rimonabant—Paranoia—Carmustine—melanoma	0.0024	0.024	CcSEcCtD
Rimonabant—Aggression—Bleomycin—melanoma	0.00213	0.0214	CcSEcCtD
Rimonabant—Disturbance in attention—Temozolomide—melanoma	0.00183	0.0183	CcSEcCtD
Rimonabant—Infestation—Vemurafenib—melanoma	0.00173	0.0173	CcSEcCtD
Rimonabant—Infestation NOS—Vemurafenib—melanoma	0.00173	0.0173	CcSEcCtD
Rimonabant—Connective tissue disorder—Vemurafenib—melanoma	0.00153	0.0153	CcSEcCtD
Rimonabant—Angiopathy—Vemurafenib—melanoma	0.00141	0.0141	CcSEcCtD
Rimonabant—Mediastinal disorder—Vemurafenib—melanoma	0.0014	0.014	CcSEcCtD
Rimonabant—Malnutrition—Vemurafenib—melanoma	0.00135	0.0135	CcSEcCtD
Rimonabant—Lethargy—Dactinomycin—melanoma	0.0013	0.013	CcSEcCtD
Rimonabant—Gastroenteritis—Temozolomide—melanoma	0.0013	0.013	CcSEcCtD
Rimonabant—Amnesia—Carmustine—melanoma	0.00126	0.0127	CcSEcCtD
Rimonabant—Hot flush—Temozolomide—melanoma	0.00123	0.0123	CcSEcCtD
Rimonabant—Amnesia—Temozolomide—melanoma	0.00122	0.0122	CcSEcCtD
Rimonabant—Menopausal symptoms—Temozolomide—melanoma	0.00122	0.0122	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00114	0.0115	CcSEcCtD
Rimonabant—Infection—Vemurafenib—melanoma	0.0011	0.011	CcSEcCtD
Rimonabant—Mood swings—Temozolomide—melanoma	0.00109	0.0109	CcSEcCtD
Rimonabant—Nervous system disorder—Vemurafenib—melanoma	0.00108	0.0108	CcSEcCtD
Rimonabant—Skin disorder—Vemurafenib—melanoma	0.00107	0.0107	CcSEcCtD
Rimonabant—Decreased appetite—Vemurafenib—melanoma	0.00096	0.00961	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Vemurafenib—melanoma	0.000953	0.00954	CcSEcCtD
Rimonabant—Fatigue—Vemurafenib—melanoma	0.000952	0.00953	CcSEcCtD
Rimonabant—Hypoaesthesia—Bleomycin—melanoma	0.000937	0.00938	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Temozolomide—melanoma	0.000922	0.00923	CcSEcCtD
Rimonabant—Depression—Carmustine—melanoma	0.000913	0.00914	CcSEcCtD
Rimonabant—Infestation—Temozolomide—melanoma	0.000885	0.00886	CcSEcCtD
Rimonabant—Infestation NOS—Temozolomide—melanoma	0.000885	0.00886	CcSEcCtD
Rimonabant—Depression—Temozolomide—melanoma	0.000882	0.00883	CcSEcCtD
Rimonabant—Sinusitis—Temozolomide—melanoma	0.00083	0.00831	CcSEcCtD
Rimonabant—Hypoaesthesia—Carmustine—melanoma	0.000818	0.00819	CcSEcCtD
Rimonabant—Hallucination—Carmustine—melanoma	0.000818	0.00819	CcSEcCtD
Rimonabant—Hot flush—Docetaxel—melanoma	0.000816	0.00817	CcSEcCtD
Rimonabant—Menopausal symptoms—Docetaxel—melanoma	0.000809	0.0081	CcSEcCtD
Rimonabant—Connective tissue disorder—Carmustine—melanoma	0.000808	0.00809	CcSEcCtD
Rimonabant—Asthenia—Vemurafenib—melanoma	0.000792	0.00793	CcSEcCtD
Rimonabant—Hypoaesthesia—Temozolomide—melanoma	0.00079	0.00791	CcSEcCtD
Rimonabant—Hallucination—Temozolomide—melanoma	0.00079	0.00791	CcSEcCtD
Rimonabant—Pruritus—Vemurafenib—melanoma	0.000781	0.00782	CcSEcCtD
Rimonabant—Connective tissue disorder—Temozolomide—melanoma	0.000781	0.00781	CcSEcCtD
Rimonabant—Lethargy—Docetaxel—melanoma	0.000779	0.0078	CcSEcCtD
Rimonabant—Diarrhoea—Vemurafenib—melanoma	0.000755	0.00756	CcSEcCtD
Rimonabant—Dizziness—Vemurafenib—melanoma	0.00073	0.00731	CcSEcCtD
Rimonabant—Angiopathy—Temozolomide—melanoma	0.000721	0.00721	CcSEcCtD
Rimonabant—Mental disorder—Carmustine—melanoma	0.00072	0.00721	CcSEcCtD
Rimonabant—Mediastinal disorder—Temozolomide—melanoma	0.000716	0.00717	CcSEcCtD
Rimonabant—Malnutrition—Carmustine—melanoma	0.000715	0.00716	CcSEcCtD
Rimonabant—Vomiting—Vemurafenib—melanoma	0.000702	0.00703	CcSEcCtD
Rimonabant—Rash—Vemurafenib—melanoma	0.000696	0.00697	CcSEcCtD
Rimonabant—Mental disorder—Temozolomide—melanoma	0.000696	0.00697	CcSEcCtD
Rimonabant—Dermatitis—Vemurafenib—melanoma	0.000696	0.00696	CcSEcCtD
Rimonabant—Headache—Vemurafenib—melanoma	0.000692	0.00693	CcSEcCtD
Rimonabant—Malnutrition—Temozolomide—melanoma	0.000691	0.00692	CcSEcCtD
Rimonabant—Cramp muscle—Docetaxel—melanoma	0.000688	0.00688	CcSEcCtD
Rimonabant—Tremor—Carmustine—melanoma	0.00067	0.00671	CcSEcCtD
Rimonabant—Infection—Bleomycin—melanoma	0.000665	0.00665	CcSEcCtD
Rimonabant—Nausea—Vemurafenib—melanoma	0.000656	0.00657	CcSEcCtD
Rimonabant—Tremor—Temozolomide—melanoma	0.000648	0.00649	CcSEcCtD
Rimonabant—Anorexia—Bleomycin—melanoma	0.000638	0.00638	CcSEcCtD
Rimonabant—Convulsion—Carmustine—melanoma	0.00062	0.00621	CcSEcCtD
Rimonabant—Infection—Dactinomycin—melanoma	0.00062	0.00621	CcSEcCtD
Rimonabant—Anxiety—Carmustine—melanoma	0.000607	0.00608	CcSEcCtD
Rimonabant—Paraesthesia—Bleomycin—melanoma	0.000601	0.00601	CcSEcCtD
Rimonabant—Convulsion—Temozolomide—melanoma	0.000599	0.006	CcSEcCtD
Rimonabant—Anorexia—Dactinomycin—melanoma	0.000595	0.00595	CcSEcCtD
Rimonabant—Infestation—Docetaxel—melanoma	0.000588	0.00589	CcSEcCtD
Rimonabant—Infestation NOS—Docetaxel—melanoma	0.000588	0.00589	CcSEcCtD
Rimonabant—Anxiety—Temozolomide—melanoma	0.000587	0.00587	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000585	0.00585	CcSEcCtD
Rimonabant—Decreased appetite—Bleomycin—melanoma	0.000582	0.00582	CcSEcCtD
Rimonabant—Infection—Carmustine—melanoma	0.00058	0.00581	CcSEcCtD
Rimonabant—Dry mouth—Temozolomide—melanoma	0.000576	0.00576	CcSEcCtD
Rimonabant—Infection—Temozolomide—melanoma	0.000561	0.00561	CcSEcCtD
Rimonabant—Anorexia—Carmustine—melanoma	0.000557	0.00557	CcSEcCtD
Rimonabant—Nervous system disorder—Temozolomide—melanoma	0.000553	0.00554	CcSEcCtD
Rimonabant—Skin disorder—Temozolomide—melanoma	0.000548	0.00549	CcSEcCtD
Rimonabant—Hyperhidrosis—Temozolomide—melanoma	0.000546	0.00546	CcSEcCtD
Rimonabant—Decreased appetite—Dactinomycin—melanoma	0.000542	0.00543	CcSEcCtD
Rimonabant—Fatigue—Dactinomycin—melanoma	0.000538	0.00539	CcSEcCtD
Rimonabant—Anorexia—Temozolomide—melanoma	0.000538	0.00539	CcSEcCtD
Rimonabant—Insomnia—Carmustine—melanoma	0.000528	0.00529	CcSEcCtD
Rimonabant—Hypoaesthesia—Docetaxel—melanoma	0.000526	0.00526	CcSEcCtD
Rimonabant—Paraesthesia—Carmustine—melanoma	0.000524	0.00525	CcSEcCtD
Rimonabant—Connective tissue disorder—Docetaxel—melanoma	0.000519	0.0052	CcSEcCtD
Rimonabant—Insomnia—Temozolomide—melanoma	0.00051	0.00511	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dactinomycin—melanoma	0.00051	0.00511	CcSEcCtD
Rimonabant—Decreased appetite—Carmustine—melanoma	0.000508	0.00508	CcSEcCtD
Rimonabant—Paraesthesia—Temozolomide—melanoma	0.000507	0.00507	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Carmustine—melanoma	0.000504	0.00505	CcSEcCtD
Rimonabant—Abdominal pain—Dactinomycin—melanoma	0.000493	0.00494	CcSEcCtD
Rimonabant—Decreased appetite—Temozolomide—melanoma	0.000491	0.00491	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Temozolomide—melanoma	0.000487	0.00488	CcSEcCtD
Rimonabant—Fatigue—Temozolomide—melanoma	0.000487	0.00487	CcSEcCtD
Rimonabant—Asthenia—Bleomycin—melanoma	0.00048	0.00481	CcSEcCtD
Rimonabant—Angiopathy—Docetaxel—melanoma	0.000479	0.0048	CcSEcCtD
Rimonabant—Gastrointestinal pain—Carmustine—melanoma	0.000477	0.00478	CcSEcCtD
Rimonabant—Mediastinal disorder—Docetaxel—melanoma	0.000476	0.00477	CcSEcCtD
Rimonabant—Pruritus—Bleomycin—melanoma	0.000473	0.00474	CcSEcCtD
Rimonabant—Mental disorder—Docetaxel—melanoma	0.000463	0.00463	CcSEcCtD
Rimonabant—Abdominal pain—Carmustine—melanoma	0.000462	0.00462	CcSEcCtD
Rimonabant—Gastrointestinal pain—Temozolomide—melanoma	0.000461	0.00462	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—melanoma	0.00046	0.0046	CcSEcCtD
Rimonabant—Asthenia—Dactinomycin—melanoma	0.000448	0.00448	CcSEcCtD
Rimonabant—Abdominal pain—Temozolomide—melanoma	0.000446	0.00447	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—melanoma	0.000442	0.00443	CcSEcCtD
Rimonabant—Diarrhoea—Dactinomycin—melanoma	0.000427	0.00427	CcSEcCtD
Rimonabant—Vomiting—Bleomycin—melanoma	0.000425	0.00426	CcSEcCtD
Rimonabant—Rash—Bleomycin—melanoma	0.000422	0.00422	CcSEcCtD
Rimonabant—Dermatitis—Bleomycin—melanoma	0.000421	0.00422	CcSEcCtD
Rimonabant—Asthenia—Carmustine—melanoma	0.000419	0.00419	CcSEcCtD
Rimonabant—Asthenia—Temozolomide—melanoma	0.000405	0.00405	CcSEcCtD
Rimonabant—Diarrhoea—Carmustine—melanoma	0.0004	0.004	CcSEcCtD
Rimonabant—Pruritus—Temozolomide—melanoma	0.000399	0.004	CcSEcCtD
Rimonabant—Convulsion—Docetaxel—melanoma	0.000398	0.00399	CcSEcCtD
Rimonabant—Nausea—Bleomycin—melanoma	0.000397	0.00398	CcSEcCtD
Rimonabant—Vomiting—Dactinomycin—melanoma	0.000397	0.00397	CcSEcCtD
Rimonabant—Rash—Dactinomycin—melanoma	0.000393	0.00394	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000389	0.00389	CcSEcCtD
Rimonabant—Dizziness—Carmustine—melanoma	0.000386	0.00387	CcSEcCtD
Rimonabant—Diarrhoea—Temozolomide—melanoma	0.000386	0.00387	CcSEcCtD
Rimonabant—Dry mouth—Docetaxel—melanoma	0.000383	0.00383	CcSEcCtD
Rimonabant—Dizziness—Temozolomide—melanoma	0.000373	0.00374	CcSEcCtD
Rimonabant—Infection—Docetaxel—melanoma	0.000373	0.00373	CcSEcCtD
Rimonabant—Vomiting—Carmustine—melanoma	0.000371	0.00372	CcSEcCtD
Rimonabant—Nausea—Dactinomycin—melanoma	0.000371	0.00371	CcSEcCtD
Rimonabant—Rash—Carmustine—melanoma	0.000368	0.00369	CcSEcCtD
Rimonabant—Nervous system disorder—Docetaxel—melanoma	0.000368	0.00368	CcSEcCtD
Rimonabant—Dermatitis—Carmustine—melanoma	0.000368	0.00368	CcSEcCtD
Rimonabant—Headache—Carmustine—melanoma	0.000366	0.00366	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—melanoma	0.000364	0.00365	CcSEcCtD
Rimonabant—Vomiting—Temozolomide—melanoma	0.000359	0.00359	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—melanoma	0.000358	0.00358	CcSEcCtD
Rimonabant—Rash—Temozolomide—melanoma	0.000356	0.00356	CcSEcCtD
Rimonabant—Dermatitis—Temozolomide—melanoma	0.000355	0.00356	CcSEcCtD
Rimonabant—Headache—Temozolomide—melanoma	0.000354	0.00354	CcSEcCtD
Rimonabant—Nausea—Carmustine—melanoma	0.000347	0.00347	CcSEcCtD
Rimonabant—Insomnia—Docetaxel—melanoma	0.000339	0.0034	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—melanoma	0.000337	0.00337	CcSEcCtD
Rimonabant—Nausea—Temozolomide—melanoma	0.000335	0.00336	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—melanoma	0.000326	0.00327	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Docetaxel—melanoma	0.000324	0.00324	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—melanoma	0.000324	0.00324	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—melanoma	0.000307	0.00307	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—melanoma	0.000297	0.00297	CcSEcCtD
Rimonabant—Asthenia—Docetaxel—melanoma	0.000269	0.0027	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—melanoma	0.000265	0.00266	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—melanoma	0.000257	0.00257	CcSEcCtD
Rimonabant—Dizziness—Docetaxel—melanoma	0.000248	0.00248	CcSEcCtD
Rimonabant—Vomiting—Docetaxel—melanoma	0.000239	0.00239	CcSEcCtD
Rimonabant—Rash—Docetaxel—melanoma	0.000237	0.00237	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—melanoma	0.000236	0.00237	CcSEcCtD
Rimonabant—Headache—Docetaxel—melanoma	0.000235	0.00235	CcSEcCtD
Rimonabant—Nausea—Docetaxel—melanoma	0.000223	0.00223	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—HIF1A—melanoma	5.95e-05	0.000348	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAP2K1—melanoma	5.91e-05	0.000346	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CD—melanoma	5.87e-05	0.000343	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—melanoma	5.82e-05	0.00034	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—KRAS—melanoma	5.75e-05	0.000336	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HS3ST5—melanoma	5.71e-05	0.000334	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KDR—melanoma	5.69e-05	0.000333	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACER3—melanoma	5.68e-05	0.000332	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HS3ST5—melanoma	5.66e-05	0.000331	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGF2—melanoma	5.62e-05	0.000329	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FN1—melanoma	5.48e-05	0.00032	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH1—melanoma	5.36e-05	0.000314	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—melanoma	5.28e-05	0.000309	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MDM2—melanoma	5.26e-05	0.000308	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CD80—melanoma	5.25e-05	0.000307	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CG—melanoma	5.24e-05	0.000307	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KIT—melanoma	5.24e-05	0.000307	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APC—melanoma	5.24e-05	0.000307	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—NRAS—melanoma	5.24e-05	0.000307	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UGT2B10—melanoma	5.2e-05	0.000304	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—melanoma	5.19e-05	0.000303	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGF—melanoma	5.18e-05	0.000303	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.13e-05	0.0003	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CB—melanoma	5.12e-05	0.000299	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK3—melanoma	5.02e-05	0.000294	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BRAF—melanoma	4.93e-05	0.000288	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—melanoma	4.92e-05	0.000288	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HRAS—melanoma	4.89e-05	0.000286	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HS3ST5—melanoma	4.83e-05	0.000283	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN1B—melanoma	4.8e-05	0.000281	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF1—melanoma	4.8e-05	0.000281	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK1—melanoma	4.78e-05	0.000279	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—melanoma	4.78e-05	0.000279	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AKT1—melanoma	4.75e-05	0.000278	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—melanoma	4.71e-05	0.000275	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—melanoma	4.7e-05	0.000275	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—melanoma	4.68e-05	0.000274	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAP2K1—melanoma	4.64e-05	0.000271	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CD—melanoma	4.61e-05	0.00027	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—melanoma	4.58e-05	0.000268	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—melanoma	4.56e-05	0.000267	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.55e-05	0.000266	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CTNNB1—melanoma	4.54e-05	0.000265	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—KRAS—melanoma	4.51e-05	0.000264	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—melanoma	4.45e-05	0.00026	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CDKN1A—melanoma	4.43e-05	0.000259	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTEN—melanoma	4.42e-05	0.000259	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGF2—melanoma	4.41e-05	0.000258	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NFKB1—melanoma	4.4e-05	0.000257	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACER3—melanoma	4.39e-05	0.000257	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLCB4—melanoma	4.32e-05	0.000253	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AKT1—melanoma	4.32e-05	0.000252	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLCB4—melanoma	4.29e-05	0.000251	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.21e-05	0.000246	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—melanoma	4.15e-05	0.000242	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MDM2—melanoma	4.13e-05	0.000241	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—melanoma	4.07e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIP4K2A—melanoma	4.07e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC6A11—melanoma	4.07e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIP4K2A—melanoma	4.03e-05	0.000236	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC6A11—melanoma	4.03e-05	0.000236	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CB—melanoma	4.02e-05	0.000235	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UGT2B10—melanoma	4.01e-05	0.000235	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—melanoma	4e-05	0.000234	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—melanoma	3.96e-05	0.000231	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTAP—melanoma	3.96e-05	0.000231	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NRAS—melanoma	3.95e-05	0.000231	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTAP—melanoma	3.92e-05	0.000229	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.89e-05	0.000228	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—melanoma	3.86e-05	0.000226	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HRAS—melanoma	3.84e-05	0.000224	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.83e-05	0.000224	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK3—melanoma	3.78e-05	0.000221	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1B—melanoma	3.77e-05	0.00022	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HS3ST5—melanoma	3.73e-05	0.000218	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—melanoma	3.73e-05	0.000218	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—melanoma	3.69e-05	0.000216	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—melanoma	3.69e-05	0.000216	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—melanoma	3.68e-05	0.000215	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—melanoma	3.67e-05	0.000215	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLCB4—melanoma	3.66e-05	0.000214	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK1—melanoma	3.6e-05	0.00021	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—melanoma	3.6e-05	0.00021	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—melanoma	3.6e-05	0.00021	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	3.6e-05	0.00021	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CTNNB1—melanoma	3.56e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PHGDH—melanoma	3.53e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—LUM—melanoma	3.53e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PHGDH—melanoma	3.49e-05	0.000204	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—LUM—melanoma	3.49e-05	0.000204	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—melanoma	3.49e-05	0.000204	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1A—melanoma	3.48e-05	0.000203	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—melanoma	3.47e-05	0.000203	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HPSE—melanoma	3.46e-05	0.000202	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NFKB1—melanoma	3.45e-05	0.000202	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC6A11—melanoma	3.44e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIP4K2A—melanoma	3.44e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HPSE—melanoma	3.43e-05	0.0002	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—melanoma	3.4e-05	0.000199	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CUBN—melanoma	3.39e-05	0.000198	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—melanoma	3.39e-05	0.000198	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CUBN—melanoma	3.36e-05	0.000197	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTAP—melanoma	3.35e-05	0.000196	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BSG—melanoma	3.28e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CSPG4—melanoma	3.28e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SDHD—melanoma	3.28e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.27e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SDHD—melanoma	3.25e-05	0.00019	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BSG—melanoma	3.25e-05	0.00019	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CSPG4—melanoma	3.25e-05	0.00019	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPAM—melanoma	3.17e-05	0.000186	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPAM—melanoma	3.15e-05	0.000184	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—melanoma	3.14e-05	0.000183	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—melanoma	3.12e-05	0.000183	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—melanoma	3.1e-05	0.000182	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRAS—melanoma	3.1e-05	0.000181	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—melanoma	3.02e-05	0.000177	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PHGDH—melanoma	2.99e-05	0.000175	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—LUM—melanoma	2.99e-05	0.000175	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK3—melanoma	2.97e-05	0.000173	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HPSE—melanoma	2.93e-05	0.000171	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—melanoma	2.89e-05	0.000169	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—melanoma	2.88e-05	0.000169	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CUBN—melanoma	2.87e-05	0.000168	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLCB4—melanoma	2.83e-05	0.000165	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK1—melanoma	2.82e-05	0.000165	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—melanoma	2.82e-05	0.000165	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SDHD—melanoma	2.78e-05	0.000162	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BSG—melanoma	2.78e-05	0.000162	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CSPG4—melanoma	2.78e-05	0.000162	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—melanoma	2.76e-05	0.000162	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLA2G6—melanoma	2.7e-05	0.000158	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPAM—melanoma	2.69e-05	0.000157	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLA2G6—melanoma	2.68e-05	0.000156	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—melanoma	2.67e-05	0.000156	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIP4K2A—melanoma	2.66e-05	0.000155	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC6A11—melanoma	2.66e-05	0.000155	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTAP—melanoma	2.59e-05	0.000151	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—melanoma	2.55e-05	0.000149	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—melanoma	2.45e-05	0.000143	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—VCAN—melanoma	2.42e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—VCAN—melanoma	2.4e-05	0.000141	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—melanoma	2.37e-05	0.000139	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PHGDH—melanoma	2.3e-05	0.000135	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LUM—melanoma	2.3e-05	0.000135	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLA2G6—melanoma	2.29e-05	0.000134	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.27e-05	0.000133	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—melanoma	2.27e-05	0.000132	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HPSE—melanoma	2.26e-05	0.000132	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CUBN—melanoma	2.22e-05	0.00013	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.2e-05	0.000128	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—melanoma	2.17e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BSG—melanoma	2.14e-05	0.000125	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CSPG4—melanoma	2.14e-05	0.000125	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SDHD—melanoma	2.14e-05	0.000125	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPAM—melanoma	2.08e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—VCAN—melanoma	2.05e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP17A1—melanoma	2.05e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP17A1—melanoma	2.03e-05	0.000119	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—melanoma	2e-05	0.000117	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2e-05	0.000117	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.97e-05	0.000115	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.94e-05	0.000114	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNA11—melanoma	1.93e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNA11—melanoma	1.91e-05	0.000112	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FASN—melanoma	1.89e-05	0.000111	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.88e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FASN—melanoma	1.87e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A5—melanoma	1.86e-05	0.000109	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A5—melanoma	1.84e-05	0.000108	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNAQ—melanoma	1.8e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CD44—melanoma	1.8e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNAQ—melanoma	1.78e-05	0.000104	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CD44—melanoma	1.78e-05	0.000104	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLA2G6—melanoma	1.76e-05	0.000103	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.74e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP17A1—melanoma	1.73e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.73e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1B1—melanoma	1.72e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.71e-05	9.99e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1B1—melanoma	1.71e-05	9.98e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.69e-05	9.87e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNA11—melanoma	1.64e-05	9.57e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FASN—melanoma	1.6e-05	9.36e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—VCAN—melanoma	1.58e-05	9.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A5—melanoma	1.58e-05	9.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNAQ—melanoma	1.52e-05	8.9e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CD44—melanoma	1.52e-05	8.9e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.51e-05	8.81e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.49e-05	8.71e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.48e-05	8.63e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1B1—melanoma	1.46e-05	8.53e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—melanoma	1.42e-05	8.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—melanoma	1.41e-05	8.22e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP17A1—melanoma	1.34e-05	7.82e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PRKCA—melanoma	1.3e-05	7.63e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ERCC2—melanoma	1.29e-05	7.57e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PRKCA—melanoma	1.29e-05	7.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.29e-05	7.53e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ERCC2—melanoma	1.28e-05	7.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNA11—melanoma	1.26e-05	7.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FASN—melanoma	1.24e-05	7.23e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A5—melanoma	1.22e-05	7.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—melanoma	1.2e-05	7.02e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNAQ—melanoma	1.17e-05	6.87e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CD44—melanoma	1.17e-05	6.87e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1B1—melanoma	1.13e-05	6.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PRKCA—melanoma	1.11e-05	6.46e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ERCC2—melanoma	1.1e-05	6.41e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.06e-05	6.21e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—melanoma	1.02e-05	5.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—melanoma	1.01e-05	5.92e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARG—melanoma	9.86e-06	5.77e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARG—melanoma	9.78e-06	5.72e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—melanoma	9.27e-06	5.42e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.08e-06	5.31e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—melanoma	8.98e-06	5.25e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—melanoma	8.91e-06	5.21e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—melanoma	8.87e-06	5.19e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—melanoma	8.79e-06	5.14e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—melanoma	8.66e-06	5.06e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PRKCA—melanoma	8.53e-06	4.99e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ERCC2—melanoma	8.46e-06	4.95e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARG—melanoma	8.36e-06	4.89e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—melanoma	7.83e-06	4.58e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—melanoma	7.76e-06	4.54e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—melanoma	7.76e-06	4.54e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—melanoma	7.69e-06	4.5e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—melanoma	7.61e-06	4.45e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—melanoma	7.51e-06	4.39e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—melanoma	6.77e-06	3.96e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—melanoma	6.71e-06	3.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—melanoma	6.68e-06	3.91e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—melanoma	6.63e-06	3.88e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—melanoma	6.57e-06	3.84e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARG—melanoma	6.45e-06	3.77e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—melanoma	5.87e-06	3.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—melanoma	5.8e-06	3.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—melanoma	5.73e-06	3.35e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—melanoma	5.12e-06	2.99e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—melanoma	5.07e-06	2.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—melanoma	4.77e-06	2.79e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—melanoma	4.73e-06	2.77e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—melanoma	4.42e-06	2.59e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—melanoma	4.04e-06	2.37e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—melanoma	3.9e-06	2.28e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—melanoma	3.87e-06	2.26e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—melanoma	3.3e-06	1.93e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—melanoma	3.12e-06	1.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—melanoma	2.55e-06	1.49e-05	CbGpPWpGaD
